Current antimicrobial usage for the management of infections in leukemic patients in Japan: Results of a survey

Clinical Infectious Diseases

Volumn 39, Issue SUPPL. 1, 2004, Pages

  Yoshida, Minoru ^a   Ohno, Ryuzo ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CEFEPIME; CEFOZOPRAN; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MEROPENEM; MICONAZOLE; PANIPENEM PLUS BETAMIPRON; PENICILLIN G; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; BACTERIAL INFECTION; CANDIDA ALBICANS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FUNGEMIA; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BACTEREMIA; FUNGEMIA; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOCOMPROMISED HOST; JAPAN; LEUKEMIA, MYELOCYTIC, ACUTE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; REMISSION INDUCTION;

EID: 3242761288     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383044     Document Type: Conference Paper

References (6)

1. Yoshida M, Tsubaki K, Kobayashi T, et al. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991. Int J Hematol 1999; 70:261-7.
2. Hughes WT, Armstrong D, Bodey GP, et al. From the Infectious Disease Society of America: guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-96.
3. Hughes WT, Armstrong D, Bodey GP, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997; 25:551-73.
4. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
5. Yoshida M. Infections in patients with hematological diseases: recent advances in serological diagnosis and empiric therapy. Int J Hematol 1997; 66:279-89.
6. Ozer H, Armitage JO, Bennett CL, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000; 18:3558-85.